Zydus Cadila gets very last approval from USFDA for Propafenone Hydrochloride Extended-Release Capsules by admin- Friday, April 23rd, 2021 04:43:01 PM
Zydus Cadila has obtained final approval from the USFDA to market Propafenone Hydrochloride ExtendedRelease Capsules USP, 225 mg, 325 mg, and 425 mg (US RLD: Rythmol Capsules). Propafenone is called an anti-arrhythmic drug. It works by way of blocking the pastime of sure electric indicators inside the coronary heart that can
purpose an irregular heartbeat.
The drug could be synthetic on the organization’s formulation manufacturing facility on the SEZ, Ahmedabad. The institution now has 315 approvals and has to this point filed over four hundred ANDAs because the graduation of the submitting method in FY 2003-04.